The Rural Health Transformation Program represents a $50 billion investment in the future of rural health care. In this episode, Coral Directors Kate Freeman and Trevor Abeyta are joined by Caitlin Westerson, Senior Director for State Policy and Advocacy at United States of Care, to explore what this program means for states, providers, and communities. Together, they unpack the opportunities and challenges in applying for funding, the role of value-based care in building sustainable models, and how states can align stakeholders to create lasting change in rural health systems.

GLP-1 medications like Ozempic and Wegovy have quickly moved from niche treatments to the center of high-stakes conversations across payers about cost, access, and coverage. In this episode, Coral Partner Alison Falb talks with Laura Rudder Huff, Vice President at Gallagher Research & Insights, about how the rise of GLP-1s is shaping employer benefit strategies, equity considerations, and policy debates.

In this episode, Coral’s Founder Meg Koepke talks with Alison Falb about her journey from CMS to FDA to Coral. We explore current policy trends and challenges in Life Sciences –what they mean for organizations navigating drug pricing reforms, coverage, and access challenges.